Skip to content
Oracle Cancer Trust
Contact Us
Donate Now
0203 475 3471

UK’s leading charity dedicated to head and neck cancer

  • What we do
    • Our work
    • Our People
    • Latest News
    • Annual Report and Account
  • Head and Neck Cancers
    • Types of Head and Neck Cancers
    • Signs and Symptoms
    • Risk factors
      • HPV
    • Diagnosing Head and Neck cancer
    • Treatment Options
      • Multidisciplinary Team
  • Support for you
    • Real life stories
  • Research
    • Research and Funding Strategy
    • Research Projects
    • Research Institutes
    • Apply for funding
    • Clinical Trials
  • Get Involved
    • Donate
      • Donate Online
      • Direct Debit
      • Oracle Friends
      • Gift Aid
      • Major Donor
    • Events and Challenges
    • Leave a gift in your will
    • Giving in memory
    • Oracle Cancer Fund
    • Peter Rhys Evans Memorial Fund
  • Contact Us

New treatments

Researching combinations of radiotherapy and DNA targeted drugs

April 28, 2020

Project led by Prof Kevin Harrington

The Institute of Cancer Research

Read More

Improving prospects for immunotherapy in head and neck cancer

April 27, 2020

PhD project led by Dr Jyoti Choudhary and Prof Kevin Harrington

The Institute of Cancer Research

Read More

A model for Adenoid Cystic Carcinoma

April 27, 2020

PhD project led by Dr Amanda Swain and Prof Kevin Harrington

The Institute of Cancer Research

Read More

New treatment options for Adenoid Cystic Carcinoma

April 27, 2020

PhD project led by Professor Arturo Sala

Brunel University, London

Read More

New viral/drug combinations for head and neck cancer

January 9, 2019
Dr Victoria Roulstone

Project led by Prof Kevin Harrington

The Institute of Cancer Research

Read More

Stopping Cancer cells from repairing themselves after radiotherapy

January 9, 2019

Identify a new drug combination that will be able to block the ability of cancer cells to repair themselves after radiotherapy treatment.

Read More

Paving the way for new gene therapy

January 9, 2019

Novel treatments for Cancer: Gene-Directed Enzyme Prodrug Therapy (GDEPT)

Read More

Using viruses to kill cancer

January 9, 2019

Sensitizing p53 mutant head and neck cancer to oncolytic virotherapy by targeting the endoplasmic reticulum (ER) stress response

Read More

MR Linac – revolutionising radiotherapy

January 9, 2019
Prof Uwe Oelfke

PhD project led by Prof Uwe Oelfke

The Institute of Cancer Research

Read More

Analysing new treatment options for Adenoid Cystic Carcinoma

January 9, 2019
Alexandra Rose

PhD project led by Dr Amanda Swain and Professor Kevin Harrington

The Institute of Cancer Research.

Read More
Older Posts »
© 2023 Oracle Cancer Trust | Powered by Beaver Builder
Our website uses cookies to analyse traffic and personalise advertising. To find out how we use this information please read our Privacy PolicyCookie settingsACCEPT Reject
Manage your Cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

You can view our Privacy Policy here.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Scroll To Top